Blog

Aug 2, 2019

Multiple chemical sensitivity syndrome and porphyria. A note of caution and concern

Posted by in category: biotech/medical

Arch Intern Med. 1997 Feb 10;157:281–5.

Growing numbers of patients suffering from many symptoms believe that they have a condition called multiple chemical sensitivity syndrome (MCSS). It has been suggested that this syndrome can be triggered by exposure to any of a large and usually incompletely defined number of natural and synthetic chemical substances. Major medical organizations, including the National Research Council and the American Medical Association, have not recognized MCSS as a clinical syndrome because of a lack of valid, well-controlled studies defining it and establishing pathogenesis or origin. Lately, some have proposed that many patients with MCSS suffer from hereditary coproporphyria. However, this purported association is based chiefly on results from a single reference laboratory of a fundamentally flawed assay for erythrocyte coproporphyrinogen oxidase.

1

Comment so far

  • Christian Caine on August 2, 2019 11:49 am

    These chemicals produced in the human vessel are triggered by bio engineering pathogens like nano- techology, smart dust etc. These invaders receive signals at which point they are programed in real time to execute a task. 99% of the task is targeting dna and mitochondria. We have a solution for all of this right now through use of holograms that reprograms the quarks particles that make up the ATOM…chessy!

Leave a reply